Kallyope Growth, Revenue, Number of Employees and Funding

Overview

Location:
Total Funding:$159.1M
Industry:Biotech
Founded:2015
Lead Investor(s):Polaris Partners, Lux Capital
Press

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

    0
  • Kallyope received $21.0M in venture funding in December 2018.
  • 0
  • Kallyope's total funding is $159.1M.

Employee Data

  • Kallyope has 56 Employees.
  • Kallyope grew their employee count by 27% last year.
  • Kallyope currently has 7 job openings.

Executive Contacts

NameTitle
Brett LauringChief Medical Officer
Ann WeberSenior VP
Iyassu SebhatHead of Chemistry and Senior Director
Shirly PintoVice President
Robert AnsteyVP Business Development
Brett LauringChief Medical Officer
Shuwen HeDirector, Discovery Cmistry
Juha LaurenChief Business Officer

What Is Kallyope?

Kallyope is a platform biotechnology company dedicated to unlocking the therapeutic potential of the gut-brain axis. The company integrates cutting-edge technologies in sequencing, computational biology, neural imaging, cellular and molecular biology, and human genetics to provide an understanding of gut-brain biology that will lead to transformational therapeutics and products that improve human health. The company's founders are Charles Zuker, Ph.D., Lasker Award winner Tom Maniatis, Ph.D. and Nobel laureate Richard Axel, M.D. Headquartered at the Alexandria Center® for Life Science in New York City. We currently have many openings across Kallyope and are searching for great candidates to become part of a highly integrated team working on the cutting edge of science to identify new approaches to human health. Check out our available jobs on our website, www.kallyope.com/careers. Don't see a position that interests you Email us anyway at careers@kallyope.com. We want to know you better.

keywords:Biotechnology,Healthcare

56

Number of Employees

N/A

Revenue (est)

7

Current Jobs

27%

Employee Growth %

$159.1M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
North Central B...
N/A2496%
Axsome Therapeu...
$4.8M310%$104.7M
Progenics Pharm...
$16.3M12115%
TG Therapeutics
$0.2M9519%
Trudeau Institu...
$10.1M7312%
BioSpherix, Ltd...
$5.3M366%
Strong Hospital
N/A14614%
Tri-Institution...
$5.3M4018%
IDEX Health & S...
$10.5M691%
Elysium Health
$7M5011%$31.2M

Kallyope News

07-Sep-19 - Kallyope Inc. Appoints Juha Lauren As Chief Business Officer

NEW YORK, Sept. 4, 2019 /PRNewswire/ -- Kallyope Inc., a leading biotechnology company focused on identifying and pursuing therapeutic ...

16-Aug-19 - Bloomberg

... co-founder and managing partner Lux Capital and a director at Shapeways, Strateos, Lux Research, Kallyope, CTRL-labs and Variant.

5-Dec-18 - Kallyope Inc. Announces $21 Million Expansion of Series B ...

NEW YORK, Dec. 5, 2018 /PRNewswire/ -- Kallyope Inc., a leading biotechnology company focused on identifying therapeutic opportunities ...

Kallyope Funding

DateAmountRoundLead InvestorsReference
2015-12-14$44.0MAPolaris PartnersArticle
2018-02-23$66.0MBArticle
2018-12-06$21.0MBArticle

Kallyope Executive Hires

DateNameTitleReference
2016-10-28Ann WeberVP Drug DiscoveryArticle
2019-02-06Brett LauringChief Medical OfficerArticle